Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EXPRE-SON-REA : Expressive Versus Neutral Own Names in Neurophysiologic Prognosis Assessment of Intensive Care Unit Comatose Patients.

NCT04798508 is registered in ClinicalTrials.gov with Centre Hospitalier St Anne as lead sponsor.

NCT NCT04798508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04798508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EXPRE-SON-REA : Expressive Versus Neutral Own Names in Neurophysiologic Prognosis Assessment of Intensive Care Unit Comatose Patients.
Lead sponsor
Centre Hospitalier St Anne
Phase
Not applicable
Overall status
Unknown status
Start date
July 30, 2020
Completion date
October 30, 2022
Enrollment
78 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

comatose, neurophysiologic abnormality